WASHINGTON--(BUSINESS WIRE)--Start-up funding strategies, regenerative medicine, RNA-based therapies and other therapeutic development opportunities are just a few of the workshop topics to be discussed during the inaugural 2008 BIO National Venture Conference, being held April 22-23 at the Hyatt Regency in Cambridge, Massachusetts. Hosted by the Biotechnology Industry Organization (BIO), this new conference will bring together an elite group of venture capital investors with fledgling and large biotechnology companies to participate in company presentations, one-on-one meetings and panel discussions featuring leading clinical and therapeutic experts.
